Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCTOPUS: Ovarian Cancer Trials of Weekly Paclitaxel - Umbrella Study
2014-005221-12Phase 2Unknown
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ovarian cancer comparing Paclitaxel plus AZD2014 with Paclitaxel plus placebo (2 arms). Primary endpoint: Progression-free survival. Status: unknown.
02
Drugs
vistusertib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on 2014-005221-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005221-12.